Business News
Glenmark introduces an ophthalmic solution for the treatment of glaucoma
Glenmark Pharmaceuticals Inc, USA on Wednesday said it launched Travoprost ophthalmic solution used in the treatment of glaucoma.
The introduction of Travoprost ophthalmic solution USP, 0.004 percent adds to the company’s portfolio of prescription eye products, said Glenmark Pharmaceuticals Executive Vice President, Jim Brown. Image source: Official website